Muir, A. J., Taghipour, M., Hassanzadeh, E., Sahni, V. A., Sainani, N., Ding, D., … Tempany-Afdhal, C. (2017). A risk prediction score based on magnetic resonance cholangiopancreatography (MRCP) accurately predicts disease progression in patients with primary sclerosing cholangitis (PSC). In HEPATOLOGY (Vol. 66, pp. 81A-81A). Washington, DC: WILEY.

Muir, Andrew J., Mehdi Taghipour, Elmira Hassanzadeh, V Anik Sahni, Nisha Sainani, Dora Ding, Catherine Jia, et al. “A risk prediction score based on magnetic resonance cholangiopancreatography (MRCP) accurately predicts disease progression in patients with primary sclerosing cholangitis (PSC).” In HEPATOLOGY, 66:81A-81A. WILEY, 2017.

Muir AJ, Taghipour M, Hassanzadeh E, Sahni VA, Sainani N, Ding D, et al. A risk prediction score based on magnetic resonance cholangiopancreatography (MRCP) accurately predicts disease progression in patients with primary sclerosing cholangitis (PSC). In: HEPATOLOGY. WILEY; 2017. p. 81A-81A.

Muir, Andrew J., et al. “A risk prediction score based on magnetic resonance cholangiopancreatography (MRCP) accurately predicts disease progression in patients with primary sclerosing cholangitis (PSC).” HEPATOLOGY, vol. 66, WILEY, 2017, pp. 81A-81A.

Muir AJ, Taghipour M, Hassanzadeh E, Sahni VA, Sainani N, Ding D, Jia C, McColgan BJ, Chung C, Myers RP, Subramanian M, McHutchison JG, Goodman ZD, Eksteen B, Manns MP, Chapman RW, Bowlus CL, Levy C, Tempany-Afdhal C. A risk prediction score based on magnetic resonance cholangiopancreatography (MRCP) accurately predicts disease progression in patients with primary sclerosing cholangitis (PSC). HEPATOLOGY. WILEY; 2017. p. 81A-81A.